Company / Current Liabilities per Share
Crinetics Pharmaceuticals, Inc. Current Liabilities per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.89
FY2025
5-year range
$0.34 / $0.89
FY2021-FY2025
Trend
+38.6%
vs FY2024
Sector context
#119 of 210
Health Care
What the data says
At $0.89, Crinetics Pharmaceuticals, Inc.'s current liabilities per share ranks #92 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 9 years, ranging from $0.34 in FY2021 to $346.62 in FY2019.
Based on SEC 10-K filings.
0.89 in FY2025 with a 5-year CAGR of +15.5%.
Increased from $0.76 to $0.89 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +20.0%
- 5-Year CAGR
- +15.5%
- 10-Year CAGR
- -
Sector benchmark
-96.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 38.6% year-over-year.
- Ranks #119 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.89 | +38.6% |
| FY2024 | $0.64 | -15.1% |
| FY2023 | $0.76 | +47.1% |
| FY2022 | $0.51 | +53.1% |
| FY2021 | $0.34 | -22.3% |
| FY2020 | $0.43 | -99.9% |
| FY2019 | $346.62 | +6677.4% |
| FY2018 | $5.11 | +681.7% |
| FY2017 | $0.65 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026